South and Central America Embolization Agents Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Coils, Plugs, Beads/ Particles, Detachable Balloons, Glue, Sponge, Liquid Embolics, Sclerosants, Precipitating Agents, and Others), Application (Oncology, Neurology, Urology, Cardiology, Peripheral Vascular Diseases, and Others), and End User (Hospitals, Cardiac Centers, Ambulatory Surgical Centers, and Others)
Market Introduction
South and Central America region for the estimating the market for the embolization agents consist of countries such as Brazil, Argentina, and rest of South and Central America. The region is expected to experience growth opportunities due to rising incidences of stroke in the countries and rise development in the healthcare systems. The market is also expected to grow due to the rising awareness about the tumors and brain aneurysms in the countries of the region. In Brazil, the ischemic stroke is the common type of neurovascular diseases, accounting 61.8% of total deaths in 2016. This data was published by a study titled as ‘The burden of stroke in Brazil in 2016: an analysis of the Global Burden of Disease study findings’ it also stated that percentage was higher among the people aged 70 years and above. However, the mortality rates due to stroke have been reduced in the country. The development and improvements in the country have led to easy access to education and technology. Also, the advancement in primary health care has focused on prevention of the stroke and other neurological disorder. Breast and cervical cancer are common in Brazil, and large segments of the population, particularly in rural areas, have limited access to health care. There isn't a well-established, systematic screening programmed in existence. Each year, an estimated 49.27 new instances of breast cancer, 18.47 new cases of cervical cancer, 6.89 new cases of endometrial cancer, and 1.19 new cases of ovarian cancer are reported per 100,000 people. In addition, across the country, institutes are working towards the growth of the cancer and neuroscience in Brazil. For instance, The Brazilian Institute of Neuroscience and Neurotechnology (BRAINN) is a São Paulo Research Foundation (FAPESP)-funded institute that inspects the molecular mechanisms underlying epilepsy, stroke, and lesions associated with these diseases. INCA is the Brazilian Ministry of Health's body in charge of developing and coordinating integrated cancer prevention and control strategies. These activities include direct, free hospital care for cancer patients under Brazil's Unified Public Health System (SUS). Thus, the developments in the neurological segments are expected to grow the embolization agents market during the forecast period.
The increasing number of COVID-19 cases in Brazil, Peru, Chile, Ecuador, and Venezuela is likely to have negative impact on the South and Central America embolization agents market. For instance, in Brazil, the number of cases has reached ~18,513,305, with 516,119 deaths, as per the world meter data of June 2021. With the onset of the second wave of COVID-19 pandemic, there has been an increasing number of cases in the South American countries. According to the International Council of Nurses, the number of deaths of health professionals in Brazil are greater than the numbers in other countries, which can be associated with the high transmission of the virus. As Brazil has many populated regions with small houses with 6-7 people per house, the virus has spread rapidly. Currently, the countries in this region are rapidly increasing its clinical programs to fight against the novel coronavirus. In this scenario, Brazil is facing enormous difficulties in the management of cancer, head and neck surgeries, chronic neurological disorders such as brain aneurysms, and headache and neurodegenerative diseases. Due to inadequate monitoring, many patients end up being admitted to emergency departments due to decompensation of their cancer and neurological disease. During the pandemic, patients with cancer and stroke, as well as other neurological conditions, have been arriving late at the hospital, and the treatment procedures of such patients fall outside the therapeutic window for acute intervention. In addition, the country also faced difficulties in obtaining beds in the intensive care unit for management of these disease amid the COVID-19 crisis. These factors are limiting the South and Central America embolization agents market growth.
Get more information on this report : 
Market Overview and Dynamics
The embolization agents market in South and Central America is expected to grow from US$ 167.17 million in 2021 to US$ 262.40 million by 2028; it is estimated to grow at a CAGR of 6.7% from 2021 to 2028. Growing incidence of hypertension, obesity, smoking, and alcoholism; Hypertension, smoking, alcoholism, and obesity are associated with the development of brain aneurysms. Thus, increasing prevalence of these diseases is likely to fuel the demand for embolization agents market. Kidney cancer is becoming more common in people of all ages, races, and tumor sizes. Hypertension, being overweight, and smoking are all risk factors for kidney cancer. Obesity is associated with high blood pressure, dyslipidemia, diabetes, or insulin resistance, as well as higher fibrinogen and C-reactive protein levels, all of which increase the risk of cardiovascular diseases (CVD) events. Obesity has been associated with a higher risk of high blood pressure, in addition to CVD. Embolizing agents like the Amplatzer Vascular Plug (AVP) was created for peripheral embolization as a modification of the family of Amplatz septal occluders used in the treatment of congenital heart malformations. Thus, increasing prevalence of hypertension, smoking, alcoholism, and obesity requiring mobility assistance is likely to favor the growth of the South and Central America embolization agents market.
Key Market Segments
Based on product, the market is segmented into coils, beads/particles, plugs, detachable balloons, glue, sponge, liquid embolics, sclerosants, precipitating agents, others. The beads/particles segment held the largest share of the market in 2020. Based on coils the market is divided into detachable coils and pushable coils. The pushable coils segment held the largest share of the market in 2020. Based on beads/particles the market is divided into spherical and non-spherical. The pushable non-spherical segment held the largest share of the market in 2020. Based on application, the market is segmented into neurology, oncology, cardiology, peripheral vascular diseases, and others. In 2020, the oncology segment is likely to hold the largest share of the market. The embolization agents market by end user, is segmented into hospitals, ambulatory surgical centers, cardiac centers, and others. The hospitals segment held the largest share of the market in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the embolization agents market in South and Central America are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Abbott; Boston Scientific Corporation; Cook Medical LLC; DePuy Synthes; KANEKA CORPORATION; Medtronic; Merit Medical Systems Inc; Stryker Corporation; and Terumo Corporation among others.
Reasons to buy report
- To understand the South and Central America embolization agents market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for South and Central America embolization agents market
- Efficiently plan M&A and partnership deals in South and Central America embolization agents market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form South and Central America embolization agents market
- Obtain market revenue forecast for market by various segments from 2021-2028 in South and Central America region.
SOUTH AND CENTRAL AMERICA EMBOLIZATION AGENTS MARKET SEGMENTATION
- Coils
- Detachable Coils
- Pushable Coils
- Beads/ Particles
- Spherical
- Non-Spherical
- Plugs
- Detachable Balloons
- Glue
- Sponge
- Liquid Embolics
- Sclerosants
- Precipitating Agents
- Others
- Oncology
- Neurology
- Urology
- Cardiology
- Peripheral Vascular Diseases
- Others
- Hospitals
- Cardiac Centers
- Ambulatory Surgical Centers
- Others
By Country
- Brazil
- Argentina
- Rest of South and Central America
Company Profiles
- Abbott
- Boston Scientific Corporation
- Cook Medical LLC
- DePuy Synthes
- KANEKA CORPORATION
- Medtronic
- Merit Medical Systems Inc
- Stryker Corporation
- Terumo Corporation
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 SCAM Embolization Agents Market – By Product
1.3.2 SCAM Embolization Agents Market – By Application
1.3.3 SCAM Embolization Agents Market – By End User
1.3.4 SCAM Embolization Agents Market – By Country
2. SCAM Embolization Agents Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. SCAM Embolization Agents Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 South and Central America (SCAM) – PEST Analysis
4.3 Experts Opinion
5. SCAM Embolization Agents Market– Key Market Dynamics
5.1 Market Drivers
5.1.1 Rise in the Incidence of Tumors and Aneurysms
5.1.1 Growing Incidence of Hypertension, Obesity, Smoking, and Alcoholism
5.2 Market Restraints
5.2.1 High Cost of Embolization Agents
5.3 Market Opportunities
5.3.1 Growing Geriatric Population Base
5.4 Future Trends
5.4.1 Technological Advancements in Embolization Products and Procedures
5.5 Impact analysis
6. Embolization Agents Market – SCAM Analysis
6.1 SCAM Embolization Agents Market Revenue Forecast and Analysis
7. SCAM Embolization Agents Market Analysis – By Product
7.1 Overview
7.2 SCAM Embolization Agents Market Revenue Share, by Products (2021 and 2028)
7.3 Coils
7.3.1 Overview
7.3.2 Coils: SCAM Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.3.2.1 Detachable Coils
7.3.2.1.1 Detachable Coil Market Revenue and Forecast to 2028 (US$ Mn)
7.3.2.1.2 Detachable Coil Market Revenue and Forecasts to 2028 (US$ Mn)
7.3.2.2 Pushable Coils
7.3.2.2.1 Pushable Coil Market Revenue and Forecast to 2028 (US$ Mn)
7.3.2.2.2 Pushable Coil Market Revenue and Forecasts to 2028 (US$ Mn)
7.4 Beads/Particles
7.4.1 Overview
7.4.2 Beads/Particles: SCAM Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.4.2.1 Spherical
7.4.2.1.1 Spherical Market Revenue and Forecast to 2028 (US$ Mn)
7.4.2.1.2 Spherical Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.2.2 Non-Spherical
7.4.2.2.1 Non-Spherical Market Revenue and Forecast to 2028 (US$ Mn)
7.4.2.2.2 Non-Spherical Market Revenue and Forecasts to 2028 (US$ Mn)
7.5 Plugs
7.5.1 Overview
7.5.2 Plugs: SCAM Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.6 Detachable Balloons
7.6.1 Overview
7.6.2 Detachable Balloons: SCAM Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.7 Glue
7.7.1 Overview
7.7.2 Glue: SCAM Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.8 Sponge
7.8.1 Overview
7.8.2 Sponge: SCAM Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.9 Liquid Embolics
7.9.1 Overview
7.9.2 Liquid Embolics: SCAM Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.10 Sclerosants
7.10.1 Overview
7.10.2 Sclerosants: SCAM Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.11 Precipitating Agents
7.11.1 Overview
7.11.2 Precipitating Agents: SCAM Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.12 Others
7.12.1 Overview
7.12.2 Others: SCAM Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
8. SCAM Embolization Agents Market Analysis – By Application
8.1 Overview
8.2 SCAM Embolization Agents Market, by Application 2021 & 2028 (%)
8.3 Oncology
8.3.1 Overview
8.3.2 Oncology: SCAM Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Neurology
8.4.1 Overview
8.4.2 Neurology: SCAM Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Urology
8.5.1 Overview
8.5.2 Urology: SCAM Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Cardiology
8.6.1 Overview
8.6.2 Cardiology: SCAM Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Peripheral Vascular Diseases
8.7.1 Overview
8.7.2 Peripheral Vascular Diseases: SCAM Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: SCAM Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
9. SCAM Embolization Agents Market Analysis – By End User
9.1 Overview
9.2 SCAM Embolization Agents Market Revenue Share, By End User (2021 and 2028)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: SCAM Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Cardiac Centers
9.4.1 Overview
9.4.2 Cardiac Centers: SCAM Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Ambulatory Surgical Centers
9.5.1 Overview
9.5.2 Ambulatory Surgical Centers: SCAM Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: SCAM Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
10. SCAM Embolization Agents Market – Country Analysis
10.1 South and Central America: Embolization Agents Market
10.1.1 Overview
10.1.2 South and Central America Embolization Agents Market, by Country, 2021 & 2028 (%)
10.1.2.1 Brazil: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.1 Brazil: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.2 Brazil: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.2.1 Brazil: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.2.2 Brazil: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.3 Brazil: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.4 Brazil: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.2.2 Argentina: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.1 Argentina: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.2 Argentina: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.2.1 Argentina: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.2.2 Argentina: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.3 Argentina: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.4 Argentina: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.2.3 Rest of South and Central America: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.1 Rest of South and Central America: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.2 Rest of South and Central America: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.2.1 Rest of South and Central America: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.3 Rest of South and Central America: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.4 Rest of South and Central America: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.5 Rest of South and Central America: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)
11. Impact Of COVID-19 Pandemic on SCAM Embolization Agents Market
11.1 South & Central America: Impact Assessment of COVID-19 Pandemic
12. SCAM Embolization Agents Market–Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 Medtronic
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Terumo Corporation
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Cook Medical LLC
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Boston Scientific Corporation
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Abbott
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Stryker Corporation
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Merit Medical Systems Inc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 DePuy Synthes
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 KANEKA CORPORATION
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. SCAM Embolization Agents Market – Revenue and Forecast to 2028 (US$ million)
Table 2. Brazil: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 3. Brazil: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)
Table 4. Brazil: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
Table 5. Brazil: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 6. Brazil: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 7. Argentina: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 8. Argentina: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)
Table 9. Argentina: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
Table 10. Argentina: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 11. Argentina: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 12. Rest of South and Central America: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 13. Rest of South and Central America: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (US$ Million)
Table 14. Rest of South and Central America: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
Table 15. Rest of South and Central America: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 16. Rest of South and Central America: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 17. Organic Developments Done by Companies
Table 18. Inorganic Developments Done by Companies
Table 19. Glossary of Terms, SCAM Embolization Agents Market
LIST OF FIGURES
Figure 1. SCAM Embolization Agents Market Segmentation
Figure 2. SCAM Embolization Agents Market Segmentation, By Country
Figure 3. SCAM Embolization Agents Market Overview
Figure 4. Beads/ Particles Segment Held the Largest Share of the Product Segment in SCAM Embolization Agents Market
Figure 5. Brazil to Show Significant Growth During Forecast Period
Figure 6. South and Central America (SCAM) PEST Analysis
Figure 7. SCAM Embolization Agents Market Impact Analysis of Drivers and Restraints
Figure 8. SCAM Embolization Agents Market – Revenue Forecast and Analysis – 2020- 2028
Figure 9. SCAM Embolization Agents Market Revenue Share, by Products (2021 and 2028)
Figure 10. Coils: SCAM Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 11. Beads/Particles: SCAM Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 12. Plugs: SCAM Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 13. Detachable Balloons: SCAM Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 14. Glue: SCAM Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 15. Sponge: SCAM Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 16. Liquid Embolics: SCAM Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 17. Sclerosants: SCAM Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 18. Precipitating Agents: SCAM Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 19. Others: SCAM Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 20. SCAM Embolization Agents Market, by Application 2021 & 2028 (%)
Figure 21. Oncology: SCAM Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Neurology: SCAM Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Urology: SCAM Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Cardiology: SCAM Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Peripheral Vascular Diseases: SCAM Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Others: SCAM Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. SCAM Embolization Agents Market Revenue Share, By End User (2021 and 2028)
Figure 28. Hospitals: SCAM Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Cardiac Centers: SCAM Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Ambulatory Surgical Centers: SCAM Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Others: SCAM Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. South and Central America: Embolization Agents Market, By Key Country – Revenue (2021) (USD Million)
Figure 33. South and Central America: Embolization Agents Market, by Country, 2021 & 2028 (%)
Figure 34. Brazil: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 35. Argentina: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 36. Rest of South and Central America: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 37. Impact of COVID-19 Pandemic in South & Central America Market
- Abbott
- Boston Scientific Corporation
- Cook Medical LLC
- DePuy Synthes
- KANEKA CORPORATION
- Medtronic
- Merit Medical Systems Inc
- Stryker Corporation
- Terumo Corporation
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South and Central America Embolization Agents Market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the South and Central America Embolization Agents Market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth South and Central America market trends and outlook coupled with the factors driving the Embolization Agents Market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution